Report Detail
Global Insomnia Pharmacological Treatment Market Insights, Forecast to 2025
- RnM2983723 |
- 19 February, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
The global Insomnia Pharmacological Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Insomnia Pharmacological Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Insomnia Pharmacological Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insomnia Pharmacological Treatment in these regions.
This research report categorizes the global Insomnia Pharmacological Treatment market by top players/brands, region, type and end user. This report also studies the global Insomnia Pharmacological Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Eisai, Co. Ltd. (Japan)
Merck & Co., Inc. (U.S.)
Meda Consumer Healthcare Inc. (U.S.)
Pfizer, Inc. (U.S.)
Sanofi (France)
Takeda Pharmaceutical Company Ltd. (Japan)
Pernix Therapeutics (U.S.)
Purdue Pharma L.P. (U.S.)
Market size by Product
Prescription Sleep Aids
Over-the-Counter Sleep Aids
Market size by End User
Homecare
Clinic
Hospital
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Insomnia Pharmacological Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Insomnia Pharmacological Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Insomnia Pharmacological Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Insomnia Pharmacological Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Insomnia Pharmacological Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Insomnia Pharmacological Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Insomnia Pharmacological Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Insomnia Pharmacological Treatment Market Size Growth Rate by Product
- 1.4.2 Prescription Sleep Aids
- 1.4.3 Over-the-Counter Sleep Aids
- 1.5 Market by End User
- 1.5.1 Global Insomnia Pharmacological Treatment Market Size Growth Rate by End User
- 1.5.2 Homecare
- 1.5.3 Clinic
- 1.5.4 Hospital
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Insomnia Pharmacological Treatment Market Size
- 2.1.1 Global Insomnia Pharmacological Treatment Revenue 2014-2025
- 2.1.2 Global Insomnia Pharmacological Treatment Sales 2014-2025
- 2.2 Insomnia Pharmacological Treatment Growth Rate by Regions
- 2.2.1 Global Insomnia Pharmacological Treatment Sales by Regions
- 2.2.2 Global Insomnia Pharmacological Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Insomnia Pharmacological Treatment Sales by Manufacturers
- 3.1.1 Insomnia Pharmacological Treatment Sales by Manufacturers
- 3.1.2 Insomnia Pharmacological Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Insomnia Pharmacological Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Insomnia Pharmacological Treatment Revenue by Manufacturers
- 3.2.1 Insomnia Pharmacological Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Insomnia Pharmacological Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Insomnia Pharmacological Treatment Price by Manufacturers
- 3.4 Insomnia Pharmacological Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Insomnia Pharmacological Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Insomnia Pharmacological Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Insomnia Pharmacological Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Insomnia Pharmacological Treatment Sales by Product
- 4.2 Global Insomnia Pharmacological Treatment Revenue by Product
- 4.3 Insomnia Pharmacological Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Insomnia Pharmacological Treatment Breakdown Data by End User
6 North America
- 6.1 North America Insomnia Pharmacological Treatment by Countries
- 6.1.1 North America Insomnia Pharmacological Treatment Sales by Countries
- 6.1.2 North America Insomnia Pharmacological Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Insomnia Pharmacological Treatment by Product
- 6.3 North America Insomnia Pharmacological Treatment by End User
7 Europe
- 7.1 Europe Insomnia Pharmacological Treatment by Countries
- 7.1.1 Europe Insomnia Pharmacological Treatment Sales by Countries
- 7.1.2 Europe Insomnia Pharmacological Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Insomnia Pharmacological Treatment by Product
- 7.3 Europe Insomnia Pharmacological Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Insomnia Pharmacological Treatment by Countries
- 8.1.1 Asia Pacific Insomnia Pharmacological Treatment Sales by Countries
- 8.1.2 Asia Pacific Insomnia Pharmacological Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Insomnia Pharmacological Treatment by Product
- 8.3 Asia Pacific Insomnia Pharmacological Treatment by End User
9 Central & South America
- 9.1 Central & South America Insomnia Pharmacological Treatment by Countries
- 9.1.1 Central & South America Insomnia Pharmacological Treatment Sales by Countries
- 9.1.2 Central & South America Insomnia Pharmacological Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Insomnia Pharmacological Treatment by Product
- 9.3 Central & South America Insomnia Pharmacological Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Insomnia Pharmacological Treatment by Countries
- 10.1.1 Middle East and Africa Insomnia Pharmacological Treatment Sales by Countries
- 10.1.2 Middle East and Africa Insomnia Pharmacological Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Insomnia Pharmacological Treatment by Product
- 10.3 Middle East and Africa Insomnia Pharmacological Treatment by End User
11 Company Profiles
- 11.1 Eisai, Co. Ltd. (Japan)
- 11.1.1 Eisai, Co. Ltd. (Japan) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Products Offered
- 11.1.5 Eisai, Co. Ltd. (Japan) Recent Development
- 11.2 Merck & Co., Inc. (U.S.)
- 11.2.1 Merck & Co., Inc. (U.S.) Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Merck & Co., Inc. (U.S.) Insomnia Pharmacological Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Merck & Co., Inc. (U.S.) Insomnia Pharmacological Treatment Products Offered
- 11.2.5 Merck & Co., Inc. (U.S.) Recent Development
- 11.3 Meda Consumer Healthcare Inc. (U.S.)
- 11.3.1 Meda Consumer Healthcare Inc. (U.S.) Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Meda Consumer Healthcare Inc. (U.S.) Insomnia Pharmacological Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Meda Consumer Healthcare Inc. (U.S.) Insomnia Pharmacological Treatment Products Offered
- 11.3.5 Meda Consumer Healthcare Inc. (U.S.) Recent Development
- 11.4 Pfizer, Inc. (U.S.)
- 11.4.1 Pfizer, Inc. (U.S.) Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Pfizer, Inc. (U.S.) Insomnia Pharmacological Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Pfizer, Inc. (U.S.) Insomnia Pharmacological Treatment Products Offered
- 11.4.5 Pfizer, Inc. (U.S.) Recent Development
- 11.5 Sanofi (France)
- 11.5.1 Sanofi (France) Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Sanofi (France) Insomnia Pharmacological Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Sanofi (France) Insomnia Pharmacological Treatment Products Offered
- 11.5.5 Sanofi (France) Recent Development
- 11.6 Takeda Pharmaceutical Company Ltd. (Japan)
- 11.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Products Offered
- 11.6.5 Takeda Pharmaceutical Company Ltd. (Japan) Recent Development
- 11.7 Pernix Therapeutics (U.S.)
- 11.7.1 Pernix Therapeutics (U.S.) Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Pernix Therapeutics (U.S.) Insomnia Pharmacological Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Pernix Therapeutics (U.S.) Insomnia Pharmacological Treatment Products Offered
- 11.7.5 Pernix Therapeutics (U.S.) Recent Development
- 11.8 Purdue Pharma L.P. (U.S.)
- 11.8.1 Purdue Pharma L.P. (U.S.) Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Purdue Pharma L.P. (U.S.) Insomnia Pharmacological Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Purdue Pharma L.P. (U.S.) Insomnia Pharmacological Treatment Products Offered
- 11.8.5 Purdue Pharma L.P. (U.S.) Recent Development
12 Future Forecast
- 12.1 Insomnia Pharmacological Treatment Market Forecast by Regions
- 12.1.1 Global Insomnia Pharmacological Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Insomnia Pharmacological Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Insomnia Pharmacological Treatment Market Forecast by Product
- 12.2.1 Global Insomnia Pharmacological Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Insomnia Pharmacological Treatment Revenue Forecast by Product 2019-2025
- 12.3 Insomnia Pharmacological Treatment Market Forecast by End User
- 12.4 North America Insomnia Pharmacological Treatment Forecast
- 12.5 Europe Insomnia Pharmacological Treatment Forecast
- 12.6 Asia Pacific Insomnia Pharmacological Treatment Forecast
- 12.7 Central & South America Insomnia Pharmacological Treatment Forecast
- 12.8 Middle East and Africa Insomnia Pharmacological Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Insomnia Pharmacological Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Insomnia Pharmacological Treatment . Industry analysis & Market Report on Insomnia Pharmacological Treatment is a syndicated market report, published as Global Insomnia Pharmacological Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Insomnia Pharmacological Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
